• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Surveillance after resection of pancreatic ductal adenocarcinoma with curative intent - a multicenter survey in Germany and review of the literature.

作者信息

Ettrich Thomas J, Schulte Lucas A, Eitel Natalie, Ettrich Kristin, Berger Andreas W, Perkhofer Lukas, Seufferlein Thomas

出版信息

Z Gastroenterol. 2017 Jul;55(7):657-666. doi: 10.1055/s-0043-105502. Epub 2017 Apr 24.

DOI:10.1055/s-0043-105502
PMID:28437802
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with high risk of relapse even after curative-intended resection. There are no evidence-based recommendations for surveillance in actual guidelines. Given this situation and as a basis for prospective studies, we wanted to determine the current practice of surveillance after pancreatic cancer resection in German institutions.  A web-based questionnaire was sent in 2015 to 300 German institutions (hospitals, outpatient clinics, and private practices) experienced in the care of patients with PDAC. The questionnaire comprised 23 items including the respective institution, the level of care, the annual case load of pancreatic cancer surgery, the surveillance algorithms used, and the most frequently used means for surveillance as well as their evaluation by the users with respect to the effectiveness of these means. Additionally, we perform a review of the literature.  The final analysis comprised 161 questionnaires (response rate 53.7 %). Mainly high-volume centers (82.5 % with > 300 hospital beds) participated. In 46.6 % of centers, more than 80 % of patients received adjuvant chemotherapy after surgery. Between 60 - 80 % of these patients completed the recommended 6 months of adjuvant treatment, and 47 % of the patients received the whole treatment (surgery, adjuvant therapy) and surveillance in the same center. Upon completion of adjuvant treatment, 96 % of centers survey their patients, and 82 % of these centers already employ diagnostic means during the course of adjuvant chemotherapy. The most commonly used diagnostic means were taking patient history, conducting physical examination, performing laboratory tests including CA19 - 9, and imaging. Of those employed, CA19 - 9 and imaging followed by patient history were considered the most efficient to detect disease relapse by the centers. Half of the institutions perform surveillance for 5 years after surgery.  This is the first systematic analysis of self-reported surveillance strategies used in Germany after resection of PDAC with curative intent. Surveillance after resection of PDAC with curative intent is common in Germany. Alterations of CA19 - 9 levels as well as imaging and taking patient history are considered the most efficient means to detect relapse of disease by the physicians participating in our survey.

摘要

相似文献

1
Surveillance after resection of pancreatic ductal adenocarcinoma with curative intent - a multicenter survey in Germany and review of the literature.
Z Gastroenterol. 2017 Jul;55(7):657-666. doi: 10.1055/s-0043-105502. Epub 2017 Apr 24.
2
Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines.胰腺腺癌手术面临的挑战——全国性调查与现行实践指南
PLoS One. 2017 Mar 7;12(3):e0173374. doi: 10.1371/journal.pone.0173374. eCollection 2017.
3
CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time.CA19-9 用于监测胰腺导管腺癌术后情况:预测复发并随时间改变预后。
Ann Surg Oncol. 2018 Nov;25(12):3483-3491. doi: 10.1245/s10434-018-6521-7. Epub 2018 May 21.
4
Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.根治性手术切除后可切除性胰腺导管腺癌患者早期复发的术前危险因素。
Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):450-455. doi: 10.1016/j.hbpd.2018.09.003. Epub 2018 Sep 7.
5
[Short- and long-term results in operable pancreatic ductal adenocarcinomas from a cooperation between two departments gastroenterology-visceral surgery at non-university hospitals benchmarked to results of expert-centers].[非大学医院胃肠病学与内脏外科两个科室合作治疗可切除胰腺导管腺癌的短期和长期结果,并与专家中心的结果进行对比]
Z Gastroenterol. 2017 Feb;55(2):140-144. doi: 10.1055/s-0042-118716. Epub 2016 Nov 22.
6
Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.根治性治疗后肺癌患者的随访和监测:肺癌的诊断和管理,第 3 版:美国胸科医师学会循证临床实践指南。
Chest. 2013 May;143(5 Suppl):e437S-e454S. doi: 10.1378/chest.12-2365.
7
Post-adjuvant chemotherapy CA19-9 levels predict prognosis in patients with pancreatic ductal adenocarcinoma: A retrospective cohort study.辅助化疗后CA19-9水平可预测胰腺导管腺癌患者的预后:一项回顾性队列研究。
Pancreatology. 2016 Jul-Aug;16(4):658-64. doi: 10.1016/j.pan.2016.04.007. Epub 2016 Apr 22.
8
Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.生物标志物panel 预测胰腺导管腺癌切除术后的生存:多机构队列研究。
Eur J Surg Oncol. 2019 Feb;45(2):218-224. doi: 10.1016/j.ejso.2018.10.050. Epub 2018 Oct 11.
9
Postoperative surveillance of pancreatic cancer patients.胰腺癌患者的术后监测。
Eur J Surg Oncol. 2019 Oct;45(10):1770-1777. doi: 10.1016/j.ejso.2019.05.031. Epub 2019 Jun 1.
10
Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.胰腺导管腺癌(PDAC)复发的术后监测:腹部放射学会PDAC疾病聚焦小组关于标准化成像和报告的实践模式
Abdom Radiol (NY). 2023 Jan;48(1):318-339. doi: 10.1007/s00261-022-03693-0. Epub 2022 Oct 14.

引用本文的文献

1
Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma.胰腺腺癌切除术后的常规影像学检查或症状性随访
JAMA Surg. 2025 Jan 1;160(1):74-84. doi: 10.1001/jamasurg.2024.5024.
2
Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic Cancer.胰腺癌切除术后的影像学检查与肿瘤标志物监测
J Clin Med. 2019 Jul 27;8(8):1115. doi: 10.3390/jcm8081115.
3
[Pancreatic ductal adenocarcinoma].[胰腺导管腺癌]
Internist (Berl). 2018 Aug;59(8):805-822. doi: 10.1007/s00108-018-0460-z.